BioAv Cancer Research Results
BioAv, bioavailability: Click to Expand ⟱
| Source: |
| Type: measurement |
Bioavailability (usually in %) absorbed by the body.
|
BC, Breast Cancer: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
| - |
in-vivo, |
Lung, |
B16-F10 |
|
|
|
- |
vitro+vivo, |
Lung, |
A549 |
|
|
|
- |
in-vitro, |
BC, |
MDA-MB-231 |
|
|
|
BioAv↓, Half-Life↓, eff↑, TumMeta↓, TumCP↓, TumCG↓, Apoptosis↑, TumCCA↑, MMP2↓, MMP9↓, VEGF↓, Bcl-2↓, eff↑, EPR↑,
BioAv↓, BioAv↑, selectivity↑, eff↑, angioG↓, *antiOx↑, *Inflam↓, MMP↓, Bcl-2↓, BAX↑, Casp9↑, Casp3↑, GRP78/BiP?, ER Stress↑, PERK↑, CHOP↑, ChemoSen↑, SESN2↑, ROS↑, MOMP↓, MAPK↑, Cyt‑c↑, AIF↑, STAT3↓, FAK↓, TIMP2↑, TumCMig↓, TumCI↓, Sp1/3/4↓, TumCCA↑, DNAdam↑,
*other↝, *BioAv↓, eff↑, toxicity↓, eff↑, TumCD↑, Half-Life↑, selectivity↑, EPR↑, ROS↑, Apoptosis↑, eff↑,
CSCs↓, *BioAv↓,
| - |
in-vitro, |
Cerv, |
HeLa |
|
|
|
- |
in-vitro, |
Liver, |
HepG2 |
|
|
|
- |
in-vitro, |
BC, |
MCF-7 |
|
|
|
- |
in-vitro, |
Lung, |
A549 |
|
|
|
- |
in-vitro, |
Nor, |
HUVECs |
|
|
|
eff↑, Dose∅, *BioAv↑, selectivity↑, TumCP↓, Casp↑, PTEN↑, TSC1↑, mTOR⇅, Akt↓, PDK1↓, E6↓, E7↓, DNAdam↑, ROS↑, *BioAv↓, *BioEnh↑, *Half-Life∅,
| - |
in-vitro, |
BC, |
4T1 |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
BioAv↓, BioAv↑, eff↑, tumCV↓, e-H2O2↓, i-H2O2∅,
Showing Research Papers: 1 to 6 of 6
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 6
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
e-H2O2↓, 1, i-H2O2∅, 1, ROS↑, 3,
Mitochondria & Bioenergetics ⓘ
AIF↑, 1, MMP↓, 1,
Core Metabolism/Glycolysis ⓘ
PDK1↓, 1,
Cell Death ⓘ
Akt↓, 1, Apoptosis↑, 2, BAX↑, 1, Bcl-2↓, 2, Casp↑, 1, Casp3↑, 1, Casp9↑, 1, Cyt‑c↑, 1, MAPK↑, 1, MOMP↓, 1, TumCD↑, 1,
Kinase & Signal Transduction ⓘ
Sp1/3/4↓, 1,
Transcription & Epigenetics ⓘ
tumCV↓, 1,
Protein Folding & ER Stress ⓘ
CHOP↑, 1, ER Stress↑, 1, GRP78/BiP?, 1, PERK↑, 1,
Autophagy & Lysosomes ⓘ
SESN2↑, 1,
DNA Damage & Repair ⓘ
DNAdam↑, 2,
Cell Cycle & Senescence ⓘ
TumCCA↑, 2,
Proliferation, Differentiation & Cell State ⓘ
CSCs↓, 1, mTOR⇅, 1, PTEN↑, 1, STAT3↓, 1, TumCG↓, 1,
Migration ⓘ
FAK↓, 1, MMP2↓, 1, MMP9↓, 1, TIMP2↑, 1, TSC1↑, 1, TumCI↓, 1, TumCMig↓, 1, TumCP↓, 2, TumMeta↓, 1,
Angiogenesis & Vasculature ⓘ
angioG↓, 1, EPR↑, 2, VEGF↓, 1,
Drug Metabolism & Resistance ⓘ
BioAv↓, 3, BioAv↑, 2, ChemoSen↑, 1, Dose∅, 1, eff↑, 8, Half-Life↓, 1, Half-Life↑, 1, selectivity↑, 3,
Clinical Biomarkers ⓘ
E6↓, 1, E7↓, 1,
Functional Outcomes ⓘ
toxicity↓, 1,
Total Targets: 54
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
antiOx↑, 1,
Transcription & Epigenetics ⓘ
other↝, 1,
Immune & Inflammatory Signaling ⓘ
Inflam↓, 1,
Drug Metabolism & Resistance ⓘ
BioAv↓, 3, BioAv↑, 1, BioEnh↑, 1, Half-Life∅, 1,
Total Targets: 7
Scientific Paper Hit Count for: BioAv, bioavailability
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:4 Cells:% prod#:% Target#:792 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page